Oxford Instruments Announcements

RNS Number : 3327I Oxford Instruments PLC 18 November 2008  
?
18th November 2008  

Oxford Instruments plc
Appointment of Non-Executive Director

Oxford Instruments plc, a leading provider of high-technology tools and systems for industry and research, is pleased to announce the appointment of Jock Fyfe Lennox as an independent non-executive director. The appointment will take effect from 1 April 2009, with a view to him succeeding Peter Morgan as Chairman of the Audit Committee in due course.  

Jock is currently a Senior Partner at Ernst & Young, where he qualified in 1980 and became a Partner in 1988. He is a Trustee of Golden Lane Housing, the property arm of Mencap, a member of the Council of The Institute of Chartered Accountants of Scotland and was a member of the CBI's Manufacturing Council from 2003 to 2006. 

There are no further details to be disclosed under paragraph 9.6.13 of the Listing Rules.
- Ends -
Enquiries:

Oxford Instruments plc
Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director

Hogarth Partnership Limited
Tel:020 7357 9477
Rachel Hirst / Andrew Jaques / Ian Payne
Notes to Editors
 
Oxford Instruments designs, supplies and supports high-technology tools, processes and solutions with a focus on physical science, bioscience, environmental and industrial research and applications. It provides solutions needed to advance fundamental nanoscience research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 40 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments is now a global company with over 1500 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors.

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments, Nuclear Magnetic Resonance, X-ray electron and optical based metrology, and advanced growth, deposition and etching. Our products, expertise, and ideas address global issues such as energy, environment, terrorism and health and are part of the next generation of telecommunications, energy products, environmental measures, security devices, drug discovery and medical advances.

This information is provided by RNSThe company news service from the London Stock Exchange  END  MSCILFLDLELDLIT